ANSTO annual report 2006-07
| dc.contributor.author | The Australian Nuclear Science and Technology Organisation | en_AU |
| dc.date.accessioned | 2009-10-23 | en_AU |
| dc.date.accessioned | 2010-04-30T04:08:38Z | en_AU |
| dc.date.available | 2009-10-23 | en_AU |
| dc.date.available | 2010-04-30T04:08:38Z | en_AU |
| dc.date.issued | 2007 | en_AU |
| dc.description.abstract | The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With approximately 950 staff, ANSTO is responsible for delivering specialised advice, scientific services and products togovernment, industry, academia and other research organisations. We do so through the development of new knowledge, the delivery of quality services and the provision of support for business opportunities. ANSTO’s nuclear infrastructure includes the Open Pool Australian Light-water reactor (OPAL), Australia’s new $470 million research reactor, particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. OPAL is Australia’s only operating nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. The High Flux Australian Reactor (HIFAR), which was Australia’s first reactor, was officially shut down in January 2007 and is currently awaiting decommissioning. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce short-lived radioisotopes for nuclear medicine procedures. ANSTO also manages access to overseas synchrotron facilities for Australian scientists. ANSTO’s main site is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. The Organisation’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and is translated into action through corporate drivers of vision, mission and strategic goals. | en_AU |
| dc.identifier.govdoc | 1 | en_AU |
| dc.identifier.issn | 1031-6655 | en_AU |
| dc.identifier.uri | http://apo.ansto.gov.au/dspace/handle/10238/2074 | en_AU |
| dc.language.iso | en | en_AU |
| dc.publisher | Australian Nuclear Science and Technology Organisation | en_AU |
| dc.relation.ispartofseries | Annual Report | en_AU |
| dc.subject | ANSTO | en_AU |
| dc.subject | Progress report | en_AU |
| dc.subject | OPAL Reactor | en_AU |
| dc.subject | Cyclotrons | en_AU |
| dc.subject | Australia | en_AU |
| dc.subject | Radiopharmaceuticals | en_AU |
| dc.title | ANSTO annual report 2006-07 | en_AU |
| dc.type | External Report | en_AU |